000 01218 a2200325 4500
005 20250515210626.0
264 0 _c20100420
008 201004s 0 0 eng d
022 _a1528-0012
024 7 _a10.1053/j.gastro.2010.02.030
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcNamee, Eóin N
245 0 0 _aCell-specific inhibition of p38alpha as a therapeutic strategy for inflammatory bowel disease.
_h[electronic resource]
260 _bGastroenterology
_cApr 2010
300 _a1237-9 p.
_bdigital
500 _aPublication Type: Comment; Editorial; Research Support, N.I.H., Extramural
650 0 4 _aAnimals
650 0 4 _aEnzyme Inhibitors
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aInflammatory Bowel Diseases
_xdrug therapy
650 0 4 _aIntestinal Mucosa
_xenzymology
650 0 4 _aMice
650 0 4 _aMitogen-Activated Protein Kinase 14
_xantagonists & inhibitors
650 0 4 _aMyeloid Cells
_xenzymology
700 1 _aCollins, Colm B
700 1 _aLebsack, Matthew D P
700 1 _aRivera-Nieves, Jesús
773 0 _tGastroenterology
_gvol. 138
_gno. 4
_gp. 1237-9
856 4 0 _uhttps://doi.org/10.1053/j.gastro.2010.02.030
_zAvailable from publisher's website
999 _c19553329
_d19553329